Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...

2026 will be a pivotal year for biopharma. From digital transformation to an AI revolution to more sustainable technologies, the forces driving change are redefining how therapies are discovered, ...